Your session is about to expire
← Back to Search
Liposomal bupivacaine for Craniotomy Surgery
Study Summary
This trial found that adding bupivacaine or liposomal bupivacaine to the standard of care for patients undergoing craniotomies resulted in better outcomes.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently breastfeeding your baby.You have had surgery on both sides of your skull.You are allergic to local numbing medicines.You had brain surgery that involved an incision outside the targeted area.You require surgery on the upper part of your brain.You are unable to understand or use a pain measurement tool called the visual analog scale (VAS).You have a known or suspected allergy to local anesthesia.You are currently taking certain medications for migraine, depression or mood disorders that may interact with the study drug.You have had a previous surgery on your scalp.
- Group 1: Liposomal Bupivacaine
- Group 2: Bupivacaine
- Group 3: Saline group
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please elucidate on any other research conducted related to Liposomal bupivacaine?
"Currently, 109 trials of Liposomal bupivacaine are in progress with a third phase encompassing 18 studies. Most of these occur in Philadelphia, Pennsylvania but the drug is being trialed at 144 other sites across the nation."
What is the current intake for this experiment?
"The trial is no longer enrolling patients, as it was first posted on September 2nd 2020 and last edited February 8th 2021. However, 1 clinical trial for craniotomy and 109 studies involving Liposomal bupivacaine are currently recruiting participants."
Are there remaining vacancies to take part in this experiment?
"According to clinicaltrials.gov's records, this specific trial does not currently require participants as its last update was on February 8th 2021. Nevertheless, there are 110 other studies actively searching for volunteers right now."
Has the Food and Drug Administration certified liposomal bupivacaine?
"Liposomal bupivacaine has been approved, thus it garnered a 3 in the safety ratings given by our team at Power."
What is Liposomal bupivacaine typically prescribed to treat?
"Liposomal bupivacaine is widely used to treat permphigus. It may also be taken as a form of treatment for acute nonspecific tenosynovitis, general anesthesia, and lupus erythematosus cell."
Share this study with friends
Copy Link
Messenger